Abstract

Aim: The purpose of this study was to examine clinical and epidemiological characteristics and autoantibody status of children diagnosed with type 1 diabetes mellitus (DM) at presentation.

Methods: The data retrieved from the medical records of 80 patients with type 1 DM, aged under 18 and diagnosed at the Adıyaman Education and Research Hospital, pediatric endocrinology clinic and emergency department between September 2016 and December 2021 were examined retrospectively. Patients’ symptoms at presentation and clinical and laboratory findings were recorded.

Results: Thirty-four (42.5%) of the children with type 1 DM were girls and 46 (57.5%) were boys, with a mean age of 10.69±4.75 years. The presentation was most common in the 5-10 (33.8%) and 10-15 (31.3%) age groups. Diabetic ketoacidosis (DKA) was present in 36 (45%) of the children with type 1 DM at presentation, ketosis without acidosis in 30 (38%), and only hyperglycemia in 14. Sixty percent of the patients under five years of age, 48% of those in the 5-10 age group, and 33.3% of the 10-18 age group presented with DKA, and the frequency of presentation with DKA was higher among patients under five years of age than in the other age groups. Severe DKA findings were present in 13 (36%) cases, moderate findings in 10 (27.8%), and mild findings in 13 (36.1%). Anti-glutamic acid decarboxylase positivity was present in 14 cases (53.2%), islet cell antibody positivity in 37 (48%), and anti-insulin antibody positivity in 11 (14.2%).

Conclusion: The incidence rate of DKA in children with newly diagnosed type 1 DM and the rate of severe ketoacidosis among them are quite high in the province of Adıyaman. This shows the need to continue diabetes awareness programs and to reach a larger number of people.

Keywords: children, diabetic ketoacidosis, type 1 diabetes mellitus

Copyright and license

Copyright © 2024 The Author(s). This is an open-access article published by Bolu İzzet Baysal Training and Research Hospital under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Bolu S, Aşık A, Bucak İH. An evaluation of clinical and epidemiological characteristics and autoantibody status of children with type 1 diabetes mellitus at presentation. Northwestern Med J. 2024;4(3):148-56. https://doi.org/10.54307/2024.NWMJ.136

References

  1. Baden MY, Imagawa A, Abiru N, et al. Characteristics and clinical course of type 1 diabetes mellitus related to anti-programmed cell death-1 therapy. Diabetol Int. 2018; 10(1): 58-66. https://doi.org/10.1007/s13340-018-0362-2
  2. Thunander M, Petersson C, Jonzon K, et al. Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract. 2008; 82(2): 247-55. https://doi.org/10.1016/j.diabres.2008.07.022
  3. Felner EI, Klitz W, Ham M, et al. Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitus. Pediatr Diabetes. 2005; 6(4): 213-20. https://doi.org/10.1111/j.1399-543X.2005.00132.x
  4. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20(7): 1183-97. https://doi.org/10.2337/diacare.20.7.1183
  5. Burrack AL, Martinov T, Fife BT. T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes. Front Endocrinol (Lausanne). 2017; 8: 343. https://doi.org/10.3389/fendo.2017.00343
  6. Fabris M, Zago S, Liguori M, et al. Anti-zinc transporter protein 8 autoantibodies significantly improve the diagnostic approach to type 1 diabetes: an Italian multicentre study on paediatric patients. Auto Immun Highlights. 2015; 6(1-2): 17-22. https://doi.org/10.1007/s13317-015-0068-4
  7. Kakleas K, Soldatou A, Karachaliou F, Karavanaki K. Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM). Autoimmun Rev. 2015; 14(9): 781-97. https://doi.org/10.1016/j.autrev.2015.05.002
  8. Mahmud FH, Elbarbary NS, Fröhlich-Reiterer E, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2018; 19(Suppl 27): 275-86. https://doi.org/10.1111/pedi.12740
  9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33(Suppl 1): S62-9. https://doi.org/10.2337/dc10-S062
  10. Wolfsdorf JI, Allgrove J, Craig ME, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2014; 15(Suppl 20): 154-79. https://doi.org/10.1111/pedi.12165
  11. Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012; 54(1): 136-60. https://doi.org/10.1097/MPG.0b013e31821a23d0
  12. Waernbaum I, Lind T, Möllsten A, Dahlquist G. The incidence of childhood-onset type 1 diabetes, time trends and association with the population composition in Sweden: a 40 year follow-up. Diabetologia. 2023; 66(2): 346-53. https://doi.org/10.1007/s00125-022-05816-0
  13. Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. JAMA. 2013; 310(4): 427-8. https://doi.org/10.1001/jama.2013.8399
  14. Çarkçı N Ş, Altuğ Özsoy S. Studying the Epidemiologic Characteristics of Children with Type 1 Diabetes Followed in İzmir. J Educ Res Nurs. 2020; 17(1): 24-31.
  15. Poyrazoğlu Ş, Bundak R, Yavaş Abalı Z, et al. Incidence of Type 1 Diabetes in Children Aged Below 18 Years during 2013-2015 in Northwest Turkey. J Clin Res Pediatr Endocrinol. 2018; 10(4): 336-42. https://doi.org/10.4274/jcrpe.0025
  16. Svensson J, Carstensen B, Mortensen HB, Borch-Johnsen K; Danish Study Group of Childhood Diabetes. Early childhood risk factors associated with type 1 diabetes-is gender important? Eur J Epidemiol. 2005; 20(5): 429-34. https://doi.org/10.1007/s10654-005-0878-1
  17. Zhao Z, Sun C, Wang C, et al. Rapidly rising incidence of childhood type 1 diabetes in Chinese population: epidemiology in Shanghai during 1997-2011. Acta Diabetol. 2014; 51(6): 947-53. https://doi.org/10.1007/s00592-014-0590-2
  18. Shaltout AA, Wake D, Thanaraj TA, et al. Incidence of type 1 diabetes has doubled in Kuwaiti children 0-14 years over the last 20 years. Pediatr Diabetes. 2017; 18(8): 761-6. https://doi.org/10.1111/pedi.12480
  19. Wändell PE, Carlsson AC. Time trends and gender differences in incidence and prevalence of type 1 diabetes in Sweden. Curr Diabetes Rev. 2013; 9(4): 342-9. https://doi.org/10.2174/15733998113099990064
  20. Kostopoulou E, Papachatzi E, Skiadopoulos S, et al. Seasonal variation and epidemiological parameters in children from Greece with type 1 diabetes mellitus (T1DM). Pediatr Res. 2021; 89(3): 574-8. https://doi.org/10.1038/s41390-020-0899-1
  21. Habeb AM, Al-Magamsi MS, Halabi S, Eid IM, Shalaby S, Bakoush O. High incidence of childhood type 1 diabetes in Al-Madinah, North West Saudi Arabia (2004-2009). Pediatr Diabetes. 2011; 12(8): 676-81. https://doi.org/10.1111/j.1399-5448.2011.00765.x
  22. Gerasimidi Vazeou A, Kordonouri O, Witsch M, et al. Seasonality at the clinical onset of type 1 diabetes-Lessons from the SWEET database. Pediatr Diabetes. 2016; 17(Suppl 23): 32-7. https://doi.org/10.1111/pedi.12433
  23. Chen YC, Tung YC, Liu SY, Lee CT, Tsai WY. Clinical characteristics of type 1 diabetes mellitus in Taiwanese children aged younger than 6 years: A single-center experience. J Formos Med Assoc. 2017; 116(5): 340-4. https://doi.org/10.1016/j.jfma.2016.07.005
  24. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010; 39(3): 481-97. https://doi.org/10.1016/j.ecl.2010.05.011
  25. Demir F, Günöz H, Saka N, et al. Epidemiologic Features of Type 1 Diabetic Patients between 0 and 18 Years of Age in İstanbul City. J Clin Res Pediatr Endocrinol. 2015; 7(1): 49-56. https://doi.org/10.4274/jcrpe.1694
  26. Cherubini V, Grimsmann JM, Åkesson K, et al. Temporal trends in diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes between 2006 and 2016: results from 13 countries in three continents. Diabetologia. 2020; 63(8): 1530-41. https://doi.org/10.1007/s00125-020-05152-1
  27. Demir K, Büyükinan M, Dizdarer C, et al. The Frequency and Associated Factors of Diabetic Ketoacidosis at Diagnosis in Children with Type 1 Diabetes. J Curr Pediatr. 2010; 8(2): 52-5.
  28. Segerer H, Wurm M, Grimsmann JM, et al. Diabetic Ketoacidosis at Manifestation of Type 1 Diabetes in Childhood and Adolescence—Incidence and Risk Factors. Dtsch Arztebl Int. 2021; 118(22): 367-72. https://doi.org/10.3238/arztebl.m2021.0133
  29. Jensen ET, Stafford JM, Saydah S, et al. Increase in Prevalence of Diabetic Ketoacidosis at Diagnosis Among Youth With Type 1 Diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2021; 44(7): 1573-8. https://doi.org/10.2337/dc20-0389
  30. Acar S, Gören Y, Paketçi A, et al. Changes in the Frequency of Diabetic Ketoacidosis in Type I Diabetes Mellitus Cases at Diagnosis: A Fifteen-Year Single Center Experience. J Pediatr Res. 2017; 4(3): 143-8. https://doi.org/10.4274/jpr.16768
  31. Usher-Smith JA, Thompson M, Ercole A, Walter FM. Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia. 2012; 55(11): 2878-94. https://doi.org/10.1007/s00125-012-2690-2
  32. Shaltout AA, Channanath AM, Thanaraj TA, et al. Ketoacidosis at first presentation of type 1 diabetes mellitus among children: a study from Kuwait. Sci Rep. 2016; 6: 27519. https://doi.org/10.1038/srep27519
  33. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A. 2007; 104(43): 17040-5. https://doi.org/10.1073/pnas.0705894104
  34. Hameed S, Ellard S, Woodhead HJ, et al. Persistently autoantibody negative (PAN) type 1 diabetes mellitus in children. Pediatr Diabetes. 2011; 12(3 Pt 1): 142-9. https://doi.org/10.1111/j.1399-5448.2010.00681.x
  35. Sabbah E, Savola K, Kulmala P, et al. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group. J Clin Endocrinol Metab. 1999; 84(5): 1534-9. https://doi.org/10.1210/jcem.84.5.5669
  36. Kahaly GJ, Hansen MP. Type 1 diabetes associated autoimmunity. Autoimmun Rev. 2016; 15(7): 644-8. https://doi.org/10.1016/j.autrev.2016.02.017
  37. Jung ES, Han DK, Yang EM, Kim MS, Lee DY, Kim CJ. Thyroid autoimmunity in children and adolescents with newly diagnosed type 1 diabetes mellitus. Ann Pediatr Endocrinol Metab. 2014; 19(2): 76-9. https://doi.org/10.6065/apem.2014.19.2.76
  38. Rinawi F, Badarneh B, Tanous O, Bashir H, Tennenbaum-Rakover Y, Peleg S. Elevated anti-tissue transglutaminase antibodies in children newly diagnosed with type 1 diabetes do not always indicate coeliac disease. Acta Paediatr. 2019; 108(1): 149-53. https://doi.org/10.1111/apa.14398